Inhalable Drugs Market Size, Share & Trends Report

Inhalable Drugs Market Size, Share & Trends Analysis Report By Product (Aerosol, Dry Powder Formulation, Spray), By Application (Respiratory & Non-Respiratory Diseases), And Segment Forecasts, 2019 - 2026

  • Report ID: GVR-3-68038-767-4
  • Number of Pages: 80
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2017
  • Industry: Healthcare

Table of Contents

Chapter 1 Methodology and Scope
                 1.1 Research Methodology
                 1.2 Research Scope and Assumptions
                 1.3 List of Abbreviations
Chapter 2 Executive Summary
                 2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
                 3.1 Market Segmentation
Chapter 4 Market Definitions
Chapter 5 Industry Outlook
                 5.1 Market Driver Analysis
                     5.1.1 Rising prevalence of respiratory and non-respiratory diseases
                     5.1.2 Rising geriatric population
                     5.1.3 advancements IN therapies
                 5.2 Market Restraint Analysis
                     5.2.1 Stringent regulations
                     5.2.2 Availability of alternative therapy
                 5.3 Key Opportunities Prioritized
Chapter 6 Business Environment Analysis
                 6.1 SWOT analysis; by factor (Political & legal, economic, and technological)
                 6.2 Porter’s five forces analysis
                 6.3 Major Deals & Strategic Alliances
                     6.3.1 Joint Ventures
                     6.3.2 Mergers and Acquisition
                     6.3.3 Licensing and Partnership
                     6.3.4 Technological Collaborations
                     6.3.5 Strategic Divestment
                     6.3.6 Market Entry Strategies
                 6.4 Respiratory Diseases Prevalence
                     6.4.1 Asthma
                     6.4.2 Chronic Obstructive Pulmonary Disease
                     6.4.3 Pulmonary Fibrosis
                     6.4.4 Cystic Fibrosis
                     6.4.5 Allergic Rhinitis (Hay fever)
                 6.5 Top Inhalable Drugs
                 6.6 Pipeline Drugs
Chapter 7 Inhalable Drugs Market: Product Estimates & Trend Analysis
                 7.1 Inhalable Drugs Market: Product Movement Analysis
                     7.1.1 Aerosol
                         7.1.1.1 Aerosol inhalable drugs market, 2014 - 2026 (USD Million)
                     7.1.2 Dry powder formulation
                         7.1.2.1 Dry powder formulation inhalable drugs market, 2014 - 2026 (USD Million)
                     7.1.3 Spray
                         7.1.3.1 Spray inhalable drugs market, 2014 - 2026 (USD Million)
Chapter 8 Inhalable Drugs Market: Application Estimates & Trend Analysis
                 8.1 Inhalable Drugs Market: Application Movement Analysis
                     8.1.1 Respiratory diseases
                         8.1.1.1 Respiratory diseases inhalable drugs market, 2014 - 2026 (USD Million)
                     8.1.2 Non-respiratory diseases
                         8.1.2.1 Non-Respiratory diseases inhalable drugs market, 2014 - 2026 (USD Million)
Chapter 9 Inhalable Drugs Market: Regional Estimates & Trend Analysis, by Product, Application
                 9.1 Inhalable Drugs Market: Regional Movement Analysis
                 9.2 North America
                     9.2.1 North America inhalable drugs market estimates and forecasts, 2014 - 2026 (USD Million)
                     9.2.2 U.S.
                         9.2.2.1 U.S. inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.2.3 Canada
                         9.2.3.1 Canada inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                 9.3 Europe
                     9.3.1 Europe inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.3.2 Germany
                         9.3.2.1 Germany inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.3.3 U.K.
                         9.3.3.1 U.K. inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.3.4 France
                         9.3.4.1 France inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.3.5 Italy
                         9.3.5.1 Italy inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.3.6 Spain
                         9.3.6.1 Spain inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                 9.4 Asia Pacific
                     9.4.1 Asia Pacific inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.4.2 Japan
                         9.4.2.1 Japan inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.4.3 China
                         9.4.3.1 China inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.4.4 India
                         9.4.4.1 India inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.4.5 South Korea
                         9.4.5.1 South Korea inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                 9.5 Latin America
                     9.5.1 Latin America inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.5.2 Brazil
                         9.5.2.1 Brazil inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.5.3 Mexico
                         9.5.3.1 Mexico inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.5.4 Argentina
                         9.5.4.1 Argentina inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                 9.6 Middle East & Africa
                     9.6.1 MEA inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.6.2 South Africa
                         9.6.2.1 South Africa inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.6.3 Saudi arabia
                         9.6.3.1 Saudi Arabia inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
                     9.6.4 UAE
                         9.6.4.1 UAE inhalable drugs market estimate and forecasts, 2014 - 2026 (USD Million)
Chapter 10 Company Profile
                 10.1 Strategy Framework
                 10.2 Company Profiles
                     10.2.1 GlaxoSmithKline plc
                         10.2.1.1 Company overview
                         10.2.1.2 Financial performance
                         10.2.1.3 Product benchmarking
                         10.2.1.4 Strategic initiatives
                     10.2.2 AstraZeneca
                         10.2.2.1 Company overview
                         10.2.2.2 Financial performance
                         10.2.2.3 Product benchmarking
                         10.2.2.4 Strategic initiatives
                     10.2.3 Boehringer Ingelheim International GmbH
                         10.2.3.1 Company overview
                         10.2.3.2 Financial performance
                         10.2.3.3 Product benchmarking
                         10.2.3.4 Strategic initiatives
                     10.2.4 Vectura Group plc
                         10.2.4.1 Company overview
                         10.2.4.2 Financial performance
                         10.2.4.3 Product benchmarking
                         10.2.4.4 Strategic initiatives
                     10.2.5 Pfizer Inc.
                         10.2.5.1 Company overview
                         10.2.5.2 Financial performance
                         10.2.5.3 Product benchmarking
                     10.2.6 Merck & Co., Inc.
                         10.2.6.1 Company overview
                         10.2.6.2 Financial performance
                         10.2.6.3 Product benchmarking
                     10.2.7 Mylan N.V.
                         10.2.7.1 Company overview
                         10.2.7.2 Financial performance
                         10.2.7.3 Product benchmarking
                         10.2.7.4 Strategic initiatives
                     10.2.8 Teva Pharmaceutical Industries Ltd.
                         10.2.8.1 Company overview
                         10.2.8.2 Financial performance
                         10.2.8.3 Product benchmarking
                         10.2.8.4 Strategic initiatives
                     10.2.9 Sunovion Pharmaceuticals Inc. (SUMITOMO DAINIPPON PHARMA)
                         10.2.9.1 Company overview
                         10.2.9.2 Financial performance
                         10.2.9.3 Product benchmarking
                         10.2.9.4 Strategic initiatives
                     10.2.10 Novartis AG
                         10.2.10.1 Company overview
                         10.2.10.2 Financial performance
                         10.2.10.3 Product benchmarking
                         10.2.10.4 Strategic initiatives
                     10.2.11 Cipla Inc.
                         10.2.11.1 Company overview
                         10.2.11.2 Financial performance
                         10.2.11.3 Product benchmarking
                         10.2.11.4 Strategic initiatives


List of Tables

Table 1 North America Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 2 North America Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 3 U.S. Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 4 U.S. Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 5 Canada Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 6 Canada Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 7 Europe Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 8 Europe Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 9 Germany Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 10 Germany Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 11 U.K. Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 12 U.K. Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 13 France Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 14 France Inhalable Drugs Market, By Application, 2014 - 2026 (USD Million)
Table 15 Italy Inhalable DrugsMarket, By Product, 2014 - 2026 (USD Million)
Table 16 Italy Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 17 Spain Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 18 Spain Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 19 Asia Pacific Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 20 Asia Pacific Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 21 Japan Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 22 Japan Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 23 China Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 24 China Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 25 India Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 26 India Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 27 South Korea Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 28 South Korea Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 29 Latin America Inhalable DrugsMarket, By Product, 2014 - 2026 (USD Million)
Table 30 Latin America Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 31 Brazil Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 32 Brazil Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 33 Mexico Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 34 Mexico Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 35 Argentina Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 36 Argentina Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 37 Middle East & Africa Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 38 Middle East & Africa Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 39 Saudi Arabia Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 40 Saudi Arabia Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 41 South Africa Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 42 South Africa Inhalable Drugs, By Application, 2014 - 2026 (USD Million)
Table 43 UAE Inhalable Drugs Market, By Product, 2014 - 2026 (USD Million)
Table 44 UAE Inhalable Drugs, By Application, 2014 - 2026 (USD Million)


List of Figures

Fig. 1 Inhalable drugs market snapshot
Fig. 2 Inhalable drugs market segmentation
Fig. 3 Inhalable drugs market driver impact
Fig. 4 Market restraint relevance analysis (Current & future impact)
Fig. 5 Key market opportunities
Fig. 6 SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 7 Porter’s five forces analysis
Fig. 8 Inhalable drugs market, Product outlook: Key takeaways
Fig. 9 Inhalable Drugs Market: Product movement analysis
Fig. 10 Aerosol inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 11 Dry powder formulation inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 12 Spray inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 13 Inhalable drugs market, application outlook: Key takeaways
Fig. 14 Inhalable drugs market: Application movement analysis
Fig. 15 Respiratory diseases inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 16 Non-respiratory diseases inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 17 Regional market place: Key takeaways
Fig. 18 Inhalable drugs market: Regional movement analysis
Fig. 19 North America
Fig. 20 North America inhalable drugs market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 21 U.S.
Fig. 22 U.S. inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 23 Canada
Fig. 24 Canada inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 25 Europe
Fig. 26 Europe inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 27 Germany
Fig. 28 Germany inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 29 U.K.
Fig. 30 U.K. inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 31 France
Fig. 32 France inhalable drugs market, 2014 - 2026
Fig. 33 Italy
Fig. 34 Italy inhalable drugs market, 2014 - 2026
Fig. 35 Spain
Fig. 36 Spain inhalable drugs market, 2014 - 2026
Fig. 37 Asia Pacific
Fig. 38 Asia Pacific inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 39 Japan
Fig. 40 Japan inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 41 China
Fig. 42 China inhalable drugs market, 2014 - 2026
Fig. 43 India
Fig. 44 India inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 45 South Korea
Fig. 46 South Korea inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 47 Latin America
Fig. 48 Latin America inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 49 Brazil
Fig. 50 Brazil inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 51 Mexico
Fig. 52 Mexico inhalable drugs market, 2014 - 2026 (USD Million)
Fig. 53 Argentina
Fig. 54 Argentina inhalable drugs market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 55 Middle East & Africa
Fig. 56 Middle East and Africa inhalable drugs market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 57 South Africa
Fig. 58 South Africa inhalable drugs market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 59 South Africa
Fig. 60 Saudi Arabia inhalable drugs market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 61 UAE
Fig. 62 UAE inhalable drugs market estimates and forecast, 2014 - 2026 (USD Million)
Fig. 63 Strategy framework

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.